Screener
Amneal Pharmaceuticals, Inc. AMRX Specialty — Product development and studies
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:ProductDevelopmentAndStudiesExpense.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 / Affordable Medicines | Three Months Ended June 30, 2026 / Specialty | Three Months Ended June 30, 2025 / Affordable Medicines | Three Months Ended June 30, 2025 / Specialty |
|---|---|---|---|---|
| Employee compensation and benefits | $12,016 | $1,326 | $14,693 | $1,279 |
| Materials and supplies | 8,796 | 1,022 | 8,108 | 450 |
| Product development and studies (1) | (89) | 2,615 | 756 | 2,371 |
| In-licensing and upfront milestones | 3,500 | — | 6,350 | — |
| Facilities costs | 1,479 | 30 | 1,793 | 735 |
| Regulatory fees | 1,334 | — | 2,932 | — |
| Other (2) | 5,987 | 1,001 | 7,267 | 1,230 |
| Total | $33,023 | $5,994 | $41,899 | $6,065 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s specialty — product development and studies?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — product development and studies of $2.62M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — product development and studies changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — product development and studies increased by 10.3% year-over-year, from $2.37M to $2.62M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — product development and studies?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — product development and studies has grown at a 57.4% compound annual growth rate (CAGR), from $2.18M to $8.52M.
- What does specialty — product development and studies mean?
- Tracks the investment in clinical trials, research studies, and technical development for new or existing specialty products. This metric is essential for evaluating the pipeline health and long-term growth potential of the segment.
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — product development and studies.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude